Found: 125
Select item for more details and to access through your institution.
Is Smoked Marijuana a Risk Factor for Chronic Obstructive Pulmonary Disease? An Enduring Controversy.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 11, p. 1474, doi. 10.1513/AnnalsATS.202405-478PS
- By:
- Publication type:
- Article
A generic fluticasone propionate and salmeterol dry powder inhaler: Evidence of usability, function, and robustness.
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 1, p. 30, doi. 10.2500/aap.2021.42.200112
- By:
- Publication type:
- Article
Flunisolide hydrofluoroalkane with integrated spacer for treating asthma: An updated review.
- Published in:
- Allergy & Asthma Proceedings, 2015, v. 36, n. 2, p. 105, doi. 10.2500/aap.2015.36.3835
- By:
- Publication type:
- Article
Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy.
- Published in:
- ACR Open Rheumatology, 2023, v. 5, n. 10, p. 547, doi. 10.1002/acr2.11598
- By:
- Publication type:
- Article
Chronic toxicity of inhaled thymol in lungs and respiratory tracts in mouse model.
- Published in:
- Pharmacology Research & Perspectives, 2019, v. 7, n. 5, p. 1, doi. 10.1002/prp2.516
- By:
- Publication type:
- Article
Pharmacokinetic study of thymol after intravenous injection and high‐dose inhalation in mouse model.
- Published in:
- Pharmacology Research & Perspectives, 2019, v. 7, n. 5, p. 1, doi. 10.1002/prp2.515
- By:
- Publication type:
- Article
Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. 1, doi. 10.1186/s13075-019-1809-y
- By:
- Publication type:
- Article
Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-1203-y
- By:
- Publication type:
- Article
Comparison of Bronchial Effects of Nabilone and Terbutaline in Healthy and Asthmatic Subjects.
- Published in:
- 1983
- By:
- Publication type:
- Other
Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT.
- Published in:
- 2022
- By:
- Publication type:
- journal article
LETTERS.
- Published in:
- 1979
- By:
- Publication type:
- Letter
Cannabis, 1977.
- Published in:
- Annals of Internal Medicine, 1978, v. 89, n. 4, p. 539, doi. 10.7326/0003-4819-89-4-539
- By:
- Publication type:
- Article
Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable COPD.
- Published in:
- International Journal of COPD, 2023, v. 18, p. 1475, doi. 10.2147/COPD.S396549
- By:
- Publication type:
- Article
Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable COPD.
- Published in:
- International Journal of COPD, 2023, v. 18, p. 1475, doi. 10.2147/COPD.S396549
- By:
- Publication type:
- Article
Chronic Obstructive Pulmonary Disease is Not Associated with In-Hospital Mortality in COVID-19: An Observational Cohort Analysis.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 3111, doi. 10.2147/COPD.S386463
- By:
- Publication type:
- Article
Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 945, doi. 10.2147/COPD.S304182
- By:
- Publication type:
- Article
Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease.
- Published in:
- International Journal of COPD, 2020, v. 15, p. 3105, doi. 10.2147/COPD.S273497
- By:
- Publication type:
- Article
Comparing Randomized Controlled Trials and Real-World Studies in Chronic Obstructive Pulmonary Disease Pharmacotherapy.
- Published in:
- International Journal of COPD, 2020, v. 16, p. 1225, doi. 10.2147/COPD.S244942
- By:
- Publication type:
- Article
Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
- Published in:
- International Journal of COPD, 2018, v. 13, p. 2587, doi. 10.2147/COPD.S172240
- By:
- Publication type:
- Article
Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease.
- Published in:
- International Journal of COPD, 2018, v. 13, p. 1873, doi. 10.2147/COPD.S162646
- By:
- Publication type:
- Article
Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.
- Published in:
- International Journal of COPD, 2018, v. 13, p. 335, doi. 10.2147/COPD.S152291
- By:
- Publication type:
- Article
A review of nebulized drug delivery in COPD.
- Published in:
- International Journal of COPD, 2016, v. 11, p. 2585, doi. 10.2147/COPD.S114034
- By:
- Publication type:
- Article
Exacerbation frequency and course of COPD.
- Published in:
- International Journal of COPD, 2012, v. 7, p. 653, doi. 10.2147/COPD.S34186
- By:
- Publication type:
- Article
Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial.
- Published in:
- International Journal of COPD, 2012, v. 7, p. 43, doi. 10.2147/COPD.S27319
- By:
- Publication type:
- Article
Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials.
- Published in:
- International Journal of COPD, 2012, v. 7, p. 73, doi. 10.2147/COPD.S29444
- By:
- Publication type:
- Article
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD.
- Published in:
- International Journal of COPD, 2012, v. 7, p. 57, doi. 10.2147/COPD.S27320
- By:
- Publication type:
- Article
Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials.
- Published in:
- International Journal of COPD, 2011, v. 6, p. 269, doi. 10.2147/COPD.S17864
- By:
- Publication type:
- Article
Preventing and managing exacerbations in COPD – critical appraisal of the role of tiotropium.
- Published in:
- International Journal of COPD, 2010, v. 5, p. 41, doi. 10.2147/copd.s9443
- By:
- Publication type:
- Article
Impairment of Antimicrobial Activity and Nitric Oxide Production in Alveolar Macrophages from Smokers of Marijuana and Cocaine.
- Published in:
- Journal of Infectious Diseases, 2003, v. 187, n. 4, p. 700, doi. 10.1086/368370
- By:
- Publication type:
- Article
Cocaine Enhances Human Immunodeficiency Virus Replication in a Model of Severe Combined Immunodeficient Mice Implanted with Human Peripheral Blood Leukocytes.
- Published in:
- Journal of Infectious Diseases, 2002, v. 185, n. 5, p. 701, doi. 10.1086/339012
- By:
- Publication type:
- Article
Supernormal Maximal Mid-Expiratory Flow Rates in Diffuse Interstitial Lung Disease.
- Published in:
- Respiration, 1981, v. 42, n. 3, p. 200, doi. 10.1159/000194429
- By:
- Publication type:
- Article
Effect of Carboxyhemoglobin on the Single Breath Diffusing Capacity: Derivation of an Empirical Correction Factor.
- Published in:
- Respiration, 1979, v. 37, n. 4, p. 185, doi. 10.1159/000194025
- By:
- Publication type:
- Article
Correction to: Benefit:Risk Profile of Budesonide in Obstructive Airways Disease.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Benefit:Risk Profile of Budesonide in Obstructive Airways Disease.
- Published in:
- Drugs, 2019, v. 79, n. 16, p. 1757, doi. 10.1007/s40265-019-01198-7
- By:
- Publication type:
- Article
Asthma: new ideas about an old disease.
- Published in:
- 1973
- By:
- Publication type:
- journal article
Induction and Regulation of the Carcinogen-Metabolizing Enzyme CYP1A1 by Marijuana Smoke and Δ<sup>9</sup>-Tetrahydrocannabinol.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2001, v. 24, n. 3, p. 339, doi. 10.1165/ajrcmb.24.3.4252
- By:
- Publication type:
- Article
Enrichment Strategies for Systemic Sclerosis–Interstitial Lung Disease Trials.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 9, p. 1067, doi. 10.1164/rccm.202401-0246ED
- By:
- Publication type:
- Article
Marijuana Use as a Risk Factor for Chronic Obstructive Pulmonary Disease: Not There Yet.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 4, p. 501, doi. 10.1164/rccm.202303-0404LE
- By:
- Publication type:
- Article
Age of Initiating Smoking: An Independent Predictor of Chronic Obstructive Pulmonary Disease in Later Life.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 4, p. 348, doi. 10.1164/rccm.202307-1146ED
- By:
- Publication type:
- Article
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
How Differential Are the Effects of Smoking Cannabis versus Tobacco on Lung Function?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
To Withdraw or Not to Withdraw Inhaled Corticosteroids from Triple Therapy in Chronic Obstructive Pulmonary Disease.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Triple Therapy for Chronic Obstructive Pulmonary Disease Management. Are Our Expectations Fulfilled?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial.
- Published in:
- Respiratory Research, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12931-015-0216-4
- By:
- Publication type:
- Article
Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD.
- Published in:
- Respiratory Research, 2014, v. 15, n. 8, p. 1, doi. 10.1186/s12931-014-0102-5
- By:
- Publication type:
- Article
Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD.
- Published in:
- 2014
- By:
- Publication type:
- journal article